Kadestone Capital Corp. has appointed Dr. Anthony Holler as Chair of Board following the Company's annual general meeting of shareholders of the Company (the "Shareholders") held on June 24, 2022 in Vancouver, British Columbia (the "Meeting"). Dr. Holler was CEO of ID Biomedical from 1999 until 2005 when the company was sold to GlaxoSmithKline for $1.7 billion.
He currently serves as the Chairman of the Board of Perimeter Medical Imaging AI Inc. and CEO and Chairman of the Board for Sunniva Inc. Previously, Dr. Holler was Chairman of the Board of Directors of CRH Medical from December 2005 to March 2020. Dr. Holler was also Chairman of Corriente Resources Inc., which sold for approximately $700 million to CRCC-Tongguan Investment Co. in 2010.
Before his involvement in public markets, Dr. Holler served as an Emergency Physician at University Hospital at the University of British Columbia. He holds a Bachelor of Science Degree and a Medical Degree from the University of British Columbia.